Full-Time

Director Clinical Operations Rare Disease

Posted on 3/29/2025

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Compensation Overview

$183k - $228.8k/yr

+ Bonus + Equity Awards

Senior, Expert

Princeton, NJ, USA + 1 more

More locations: San Diego, CA, USA

Hybrid role requiring some in-office presence; ability to travel 25% of the time.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • A bachelor’s degree in the life sciences, a related field, or an advanced degree is preferred
  • Targeting 10 years of clinical development and management experience
  • Significant clinical trial experience
  • 8 years of proven experience in a leadership and people management role
  • An equivalent combination of relevant education and experience may be considered
Responsibilities
  • Responsible for the development and management of all operational timelines and budgets for programs under the respective therapeutic area
  • Responsible for providing operational input for development plans in support of the asset strategy
  • Represent the respective therapeutic area for senior management as needed
  • Leads the strategy and tactics to successfully work with vendors, investigators, other departments within ACADIA, and the program clinicians to develop, execute, and deliver clinical programs supporting drug development while ensuring quality, speed, budget, and regulatory compliance
  • Evaluates, refines, and makes recommendations for various operational constructs for study execution
  • Leads and shares best practices with internal and external stakeholders, as appropriate
  • Establishes performance, quality, business efficiency, and innovation metrics for clinical teams; addresses systematic deficiencies and seeks to improve quality across study programs
  • Maintains awareness of industry trends and developments to help define the future strategic direction for the clinical programs
  • Provides direction in the development and oversight of study plans to ensure quality processes are followed
  • Responsible for the direct management of Clinical Operations team members in the respective therapeutic area to ensure consistent application of best practice and execution
  • Supports mentoring and training of Clinical Operations staff in the respective therapeutic area
  • Participates in and/or leads process improvements within/between cross-functional areas to increase efficiencies and manage costs
  • Develops and measures appropriate metrics to assess and improve vendor and site performance
  • Ensures that cross-functional process efficiencies are identified and maximized in accordance with project goals
  • Oversees and is accountable for appropriate resource planning to support the specific therapeutic area
  • Participates in the selection, management, and oversight of CROs and other vendors, driving quality performance to milestones and deliverables
  • Other responsibilities as required
Desired Qualifications
  • Experience leading and managing complex global clinical development programs is required
  • Superior verbal, written, and presentation communication skills in relating to colleagues and associates both inside and outside the organization
  • Demonstrated track record of translating senior-level research/scientific business requirements into operational strategies globally
  • Has broad experience selecting, managing, troubleshooting, and negotiating with CROs and other vendors
  • Thorough understanding of local and international regulations applicable to clinical development; demonstrable knowledge of regulatory requirements globally, and prior success in providing timely and quality support of regulatory submissions
  • Practical experience in clinical trial strategies, methods, and processes; deep knowledge of clinical trial design
  • Demonstrated technical, administrative, and project management capabilities
  • Adept at creating and communicating a clear vision among direct reports, effectively aligning resources, and motivating teams to achieve goals
  • Demonstrated analytical abilities and proficient planning and negotiation skills
  • Strong interpersonal, organizational, and workload planning skills, along with excellent verbal and written communication skills
  • Demonstrated success with cross-functional collaboration and managing multiple assignments with timely and accurate output
  • Ability to travel 25% of the time
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these conditions while also promoting diversity and inclusion within their operations.

Company Size

501-1,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased focus on personalized medicine benefits Acadia's tailored CNS therapies.
  • FDA's supportive regulatory environment aids Acadia's innovative CNS disorder treatments.
  • Growing interest in rare diseases supports Acadia's Rett syndrome treatment efforts.

What critics are saying

  • Increased competition from Biogen and Roche may impact Acadia's market share.
  • Litigation risks from class action lawsuit could lead to financial liabilities.
  • Challenges in DAYBUE's market adoption and reimbursement negotiations may affect commercialization.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on CNS disorders with a strong pipeline including pimavanserin.
  • The company collaborates with Biovail and Stoke Therapeutics for innovative drug development.
  • Acadia's DAYBUE is a pioneering treatment for Rett syndrome in the U.S.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
ETF Daily News
Mar 27th, 2025
Cibc World Markets Corp Invests $206,000 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Cibc World Markets Corp invests $206,000 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).

Fierce Pharma
Dec 9th, 2024
Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead

Acadia Pharmaceuticals has hired Big Pharma veteran Thomas Andrew Garner as its new chief commercial officer (CCO).

MarketWatch
Nov 26th, 2024
Acadia Pharmaceuticals in Exclusive License Agreement With Saniona for SAN711

Acadia Pharmaceuticals on Tuesday said it entered into an exclusive worldwide license agreement with Saniona to develop and commercialize SAN711.

World Pharmaceuticals
Oct 17th, 2024
Acadia gets Health Canada approval for Daybue to treat Rett Syndrome

US-based biopharmaceutical company Acadia Pharmaceuticals has received Health Canada marketing authorisation for Daybue (trofinetide) to treat a rare genetic neurological disorder.

PRWeb
Aug 23rd, 2024
Global Genes' Annual Week In Rare Event Heading To Kansas City

"Week in RARE provides advocates a unique opportunity to participate in multiple events in one place to maximize their time, travel, and potential to gain benefits from their participation."

INACTIVE